As expected, without CD8+ cells, the RMs did not control viral replication, reinforcing recent reports that when CD8+ cells are depleted, anti-α4β7 therapy fails at maintaining viral control during SIV-nef-stop infection (27). This evidence concerns the gene CD8A and infection.